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Summary 
Cancer represents a major public health concern in Australia.  Causes of cancer are multifactorial with 
lack of physical activity being considered one of the known risk factors, particularly for breast and 
colorectal cancers.  Participating in exercise has also been associated with benefits during and 
following treatment for cancer, including improvements in psychosocial and physical outcomes, as 
well as better compliance with treatment regimens, reduced impact of disease symptoms and 
treatment-related side effects, and survival benefits for particular cancers.  The general exercise 
prescription for people undertaking or having completed cancer treatment is of low to moderate 
intensity, regular frequency (3-5 times/week) for at least 20 minutes per session, involving aerobic, 
resistance or mixed exercise types.  Future work needs to push the boundaries of this exercise 
prescription, so that we can better understand what constitutes optimal, desirable and necessary 
frequency, duration, intensity and type, and how specific characteristics of the individual (e.g., age, 
cancer type, treatment, presence of specific symptoms) influence this prescription.  What follows is a 
summary of the cancer and exercise literature, in particular the purpose of exercise following 
diagnosis of cancer, the potential benefits derived by cancer patients and survivors from participating 
in exercise programs, and exercise prescription guidelines and contraindications or considerations for 
exercise prescription with this special population. This report represents the position stand of the 
Australian Association of Exercise and Sport Science on exercise and cancer recovery and has the 
purpose of guiding Accredited Exercise Physiologists in their work with cancer patients.      
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Exercise and Cancer Prevention 
One in three Australian men and one in four women will be directly affected by cancer before the age 
of 75, with melanoma, prostate, colorectal, breast and lung cancers comprising the most common 
types[1].  There are an estimated 108,000 new cancer cases and 41,000 registered cancer deaths each 
year in Australia, and consequently cancer represents a major public health concern[2].  While the 
causes for many cancers remain unknown, lifestyle factors including physical activity levels are 
considered contributory and modifiable for some[3, 4]. Since the first report linking physical activity 
and cancer risk was published in 1922, more than 190 reports from epidemiological studies and over 
10 reviews have examined this relationship[5]. The scientific evidence supporting physical activity as 
a means of cancer prevention is now considered ‘strong’ and ‘convincing’ for particular cancers 
including colon/colorectal and breast, ‘probable’ for prostate and ‘possible’ for lung and endometrial 
cancers, with risk ratios or odds ratios reported for the physically active groups ranging from 0.3-0.8 
(representing risk reductions of 25% to more than three-fold)[5]. Evidence to date is considered 
preliminary and insufficient to make any causal inferences for melanoma, testicular, ovarian, kidney, 
pancreatic and thyroid cancers[5].  A review and analysis of the potential biological mechanisms 
underlying the possible anti-carcinogenic effects of physical activity has recently been published and 
gives the relationship more credibility[6].  The precise exercise prescription, in relation to type, 
intensity, duration and frequency, needed for cancer protection remains unknown[7].  However, since 
exercise prescription in this setting is not only about the prevention of cancer, but more broadly 
encompasses prevention of chronic disease and optimising health, quality of life and function, it seems 
relevant for the application of national physical activity guidelines.  Of note, published evidence 
supports a dose-response relationship between physical activity levels and some cancers including 
colorectal, breast and prostate, showing that cancer risk decreases as activity levels increase.  
Therefore, the notion that some activity is better than none, and more activity is generally better than 
less (at least up to levels meeting national guidelines), should be considered when prescribing exercise 
to healthy populations.   
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Exercise and Cancer Recovery 
Survival prospects following cancer diagnosis are increasing, with females experiencing higher 
survival probabilities than males (five-year relative survival rates are 64% and 58%, respectively)[1].  
For some of the more common forms of cancer, five-year survival prospects are even higher: 
melanoma, 92%; breast, 88%; prostate, 85%[1]. Whether treatment intention is curative or palliative, 
the disease and treatment-related side-effects may create numerous problems for the patient.  Alone or 
in combination, cancer treatments including surgery, radiation and systemic chemo- or hormone 
therapy can lead to a range of complications including loss of function (musculoskeletal, 
cardiovascular, cardiopulmonary), infections, diarrhoea, pain, numbness, lymphoedema, nausea, 
fatigue, reduction in bone mass, and body composition changes, to name a few[8]. While the presence 
of side-effects tends to peak during treatment, symptoms may persist for many months or even years 
following treatment[9] and some complications, such as lymphoedema, may not present until several 
years following treatment[10].  Furthermore, cancer and its associated treatment may increase risk of 
other common chronic conditions, such as cardiovascular disease, diabetes and osteoporosis[11].  Of 
all the potential side-effects during and following cancer treatment, fatigue is regarded as one of the 
most common and disabling[12]. 
  
Objective of exercise prescription following a cancer diagnosis 
The potential and expected benefits derived from participation in exercise will vary according to 
timing of cancer treatment, as well as whether treatment was considered successful (that is, patient no 
longer has evidence of disease)[11].  Courneya and Friedenreich[13] developed the Physical activity 
and cancer control framework (PACC), which suggests researchers and clinicians [and allied health 
professionals such as Accredited Exercise Physiologists (AEPs)] consider the following periods and 
clinical outcomes from the point of diagnosis, with respect to exercise prescription: treatment 
preparation/coping before treatment, treatment effectiveness/coping during treatment, 
recovery/rehabilitation, disease prevention/health promotion and survival during ‘survivorship’ (the 
period between diagnosis and recurrence or death) and palliation for those approaching the end of life. 
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In the Australian context, the treatment preparation period before treatment is limited to select cases 
(e.g. ‘watchful waiting’ following a diagnosis of lymphoma) as the time between cancer diagnosis and 
surgical or adjuvant treatment is typically minimal for most cancers (usually 1-2 weeks).  Therefore, 
AEPs are more likely to play a significant role during and following cancer treatment, in the 
prevention of treatment-related concerns, reducing the impact of these when they exist, overcoming 
side-effects and generally assisting this population to ‘bridge the gap’ between treatment cessation and 
effectively returning to ‘normal’ daily lives.  Further, the potential role of AEPs and exercise 
prescription extends to improvement of long-term health through optimising function, as well as 
prevention of cancer recurrence and other chronic disease. 
 
Exercise and quality of life following cancer 
Over 70 exercise intervention trials have been conducted, mostly involving women with breast cancer 
in North America (i.e. USA and Canada).  This literature is examined in several qualitative, narrative 
reviews[8, 9, 14-20], which together indicate that exercise during and/or following treatment prevents 
decline and/or improves cardiorespiratory and cardiovascular function, improves body composition 
(preservation or increase in muscle mass, loss of fat mass), improves immune function, improves 
strength and flexibility, improves body image, self-esteem and mood, reduces the number and severity 
of side-effects including nausea, fatigue and pain, reduces hospitalisation duration, improves 
chemotherapy completion rates, allows for better adjustment to illness, and reduces stress, depression 
and anxiety, all of which contribute to improvements in quality of life (Table 1).  While impressive 
findings, conclusions from such narrative reviews emphasise consistency and direction of findings but 
do not consider the magnitude of the observed effects[11].  Hence the potential clinical relevance of 
the ‘exercise effect’ cannot be derived from these reviews and the potential public health impact 
remains unknown.  More recently, the results from several meta-analyses, conducted on the exercise 
and cancer recovery literature, have been published[11, 21-23].  The results demonstrate persuasive 
findings for a small (weighted mean effect size [WMES] = 0.2-0.5) to moderate (WMES = 05-0.8) 
effect of physical activity interventions on specific outcomes, in particular cardiovascular and 
cardiorespiratory fitness (WMES = 0.5, p<0.01), activity levels (WMES = 0.3, p=0.01), physiologic 
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outcomes such as blood transfusions, blood counts, days in hospital (WMES = 0.3, P<0.01) and 
symptoms/side-effects (WMES = 0.4, p<0.01) during treatment, as well as fitness (WMES = 0.7, 
p<0.01) and vitality (WMES = 0.8, p<0.04) following treatment[11, 21].  The results for fatigue were 
less compelling (WMES = 0.1, p=0.12).  While exercise does not exacerbate fatigue, the reductions 
reported in the literature may not be of sufficient magnitude to be meaningful for the patient[11].  
However, anecdotally, patients do report reductions in fatigue and it is therefore plausible that the 
lower mean effect size is attributable to the sensitivity of the tools used to capture fatigue.  
Nonetheless, it is important to remember that the implementation of appropriate exercise prescription 
(that is, individualised with respect to starting point and speed of progression) minimises risk of injury 
and optimises the potential for individual gain.  Exercise under these circumstances, at worst, does no 
harm, but more likely leads to a range of benefits during and following treatment (Table 1) that in turn 
positively influence quality of life.  Furthermore, lack of physical activity during and/or following 
cancer treatment has the potential to exacerbate symptoms (e.g. fatigue) and contribute to loss of 
function (musculoskeletal and cardiovascular health), hence contributing to reductions in quality of 
life[24]. 
 
Exercise and survival following cancer 
While the literature examining the role of physical activity on quality of life following cancer 
diagnosis is vast (with over 70 exercise trials being conducted), only more recently have results from 
observational studies of colon/colorectal and breast cancer patients examined the relationship between 
exercise and survival[25-30].  Since 2005, several papers have reported positive associations between 
participation in physical activity following breast[28-31] or colorectal[25-27] cancer diagnosis with 
improved survival and reduced risk of recurrence.  The findings indicate that participation in physical 
activity reduces the risk of recurrence and death by up to half, when compared with those who are 
sedentary (engaging in less than 3 metabolic equivalent-task hours per week of activity).  A change in 
activity level from pre- to post-diagnosis was also important, with those who increased their activity 
levels following cancer diagnosis reducing their risk of death[25, 31], while those who decreased their 
activity levels increasing their risk four-fold[31].   There is also evidence suggesting a dose-response 
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relationship exists, with some exercise being better than none and more better than less[26].  
Unfortunately, the lower threshold for attaining survival benefits, as well as the upper threshold 
beyond which no further survival benefit is accrued, remain unknown.  While there is much to be 
learned with respect to physical activity and survival following cancer, particularly for cancers other 
than breast and colorectal, these findings are promising and exciting.  Further investigations through 
randomised, controlled trials are currently underway. 
 
Exercise prescription – boundaries of evidence 
Exercise interventions have focused predominantly on women with breast cancer, although effects 
have been investigated with other patients, including those with head and neck, lung, ovarian, 
testicular, stomach, colorectal and prostate cancers, melanoma, cancer during childhood and 
adolescence, as well as those undertaking bone marrow transplant treatment.  The effects of aerobic-
based exercise, in particular walking and stationary cycling, have received the greatest attention, either 
alone or in combination with resistance training.  Fewer studies have assessed exercise protocols 
comprised solely of resistance training.  Tested interventions usually included at least three exercise 
sessions per week of at least 15 minutes duration, at moderate intensities.  However, these prescriptive 
characteristics vary across studies: aerobic-based exercise - frequency ranged from 1-6 days/week; 
duration ranged from 10-60 minutes per session; and intensity ranged from low to moderately-high 
(50-85% of maximal effort/heart rate); resistance-based exercise, frequency ranged from 2-3 
times/week;  exercising both large muscle groups (e.g., leg press, chest press) and smaller muscle 
groups (e.g. bicep curls) by doing 1-4 sets of 6-20 repetitions at intensities of 50-80% of one-repetition 
maximum (1-RM) or to tolerance or failure.  This information is presented to highlight the limits of 
our exercise prescription knowledge and what follows are recommendations based on what can be 
derived from current research. 
 
Exercise prescription recommendations 
Recommendations for aerobic-based exercise prescription for cancer patients and survivors is 
provided in Table 2.   
 8
 
Recommendations for resistance-based exercise prescription for cancer patients and survivors is 
provided in Table 3.   
 
The current literature does not allow inferences to be made about the lower and upper thresholds of 
exercise required to achieve benefits, nor which types of exercise or modes of delivery are optimal.  
Exercise adherence, when reported, is similar irrespective of whether the exercise prescribed was 
aerobic-only, resistance-only or mixed.  While future work is required to better understand what 
constitutes optimal exercise prescription and how specific characteristics of individuals (e.g., age, 
cancer type, treatment, presence of specific symptoms) influence this prescription, we know enough to 
positively influence the lives of those undergoing and recovering from cancer treatment.  On current 
knowledge, it is recommended that both aerobic and resistance exercise be prescribed, unless specific 
problems dictate otherwise.  Exercise, starting at appropriate levels and progressing at a pace that 
reflects the individual’s personal circumstances, is an important component of cancer recovery. 
 
Special Considerations for Exercise Prescription with this Population 
Individuals with a cancer diagnosis are considered a special population in terms of exercise 
prescription.  A range of factors, beyond those usually encountered when providing exercise advice, 
must be taken into account, particularly when individuals are undergoing treatment or experiencing 
cancer-related side-effects or complications.  
• Communication with treating specialists is necessary.  Working in collaboration with the treating 
specialist/s ensures all necessary contraindications and clinical concerns are known and 
appropriately taken into account, and the treating specialist/s are aware and involved with the 
complementary therapies being prescribed.  Further, acknowledgement and support by the treating 
specialist is crucial for compliance and adherence to the exercise program[16]. 
• Exercise programs need to be flexible, particularly during periods of cancer treatment.  Programs 
need to be adjusted according to changes in treatment, presence of side-effects, functional and 
physical status of the patient, and presence of contraindications and clinical concerns. Practically, 
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this may involve prescribing or helping an individual to develop two exercise goals: one that can 
be accomplished when the presence of side-effects are intense (sometimes referred to by patients 
as ‘I’m having a bad day’) and another that is relevant for when side-effects are better tolerated 
(‘good day’).  Additionally, steady progress in relation to this population may mean regular 
participation in exercise compared with continual progression of intensity/duration/frequency. 
• The potential for psychosocial benefits should not be overlooked and is an important consideration 
during exercise prescription.  AEPs need to prescribe exercise that takes into account the wants as 
well as the needs of the cancer survivor, and at the same time, to ensure the exercise program is 
enjoyable and builds confidence. AEPs should also take the time to identify and educate cancer 
survivors of the specific cancer-related benefits of exercise (as outlined in this position stand), as 
this information, particularly when presented in an individualised format, can be a valuable source 
of motivation. 
• Maintaining clear and comprehensive documentation is vital: 
o Each session should involve the assessment and reporting of prior, current and future 
treatment, current symptoms and medical condition (and any changes in health or 
condition since last session), as well as information specific to exercise.  An AEP 
regularly seeing a patient during or following cancer treatment can play an important role 
in the early detection of worsening symptoms that could be assisted with other forms of 
treatment (e.g. pharmaceutical, physiotherapy) or that could be indicative of recurrence or 
progressive disease.  The role of the AEP is not in diagnosis but acknowledgement of 
adverse changes and appropriate referral back to the treating physician.  Further, any 
advice and assistance should be solely in relation to exercise.  Patients seeking advice in 
areas other than exercise should be referred back to the treating physician or other relevant 
allied health professional.    
o One major exercise barrier is fear of exacerbating pre-existing treatment-related symptoms 
(e.g. a fatigued patient may worry that exercise will exacerbate his/her fatigue) or cause 
side-effects (e.g. lymphoedema).  It is important for the AEP to assist the patient in 
identifying the link, or lack thereof, of the presentation or worsening of side-effects with 
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exercise.  Keeping a diary of the frequency and intensity of side-effects, alongside 
participation in exercise, treatment being undertaken, work-days and any other potentially 
relevant information, will help the patient and the AEP to identify whether there is an 
association with a worsening or unusual symptom and exercise or whether the exercise 
prescription needs to be revised.   
o Exercise is considered to be generally well-tolerated during and following cancer 
treatment and is considered safe.  However, it is important to avoid complacency with 
exercise prescription advice with this population.  The published literature is potentially 
biased towards the reporting of positive effects from exercise prescription. Participants of 
exercise and cancer studies are likely to be healthier than those who did not wish to 
participate in such studies.  Those with worsening side-effects, symptoms or disease states 
were more likely to withdraw from studies and may not have been included in the analysis 
of results. Therefore, clear documentation, as well as common-sense, will help determine 
whether physical activity plays any role in the development of symptoms or worsening 
health state, should this occur.   
• It is important to not lose sight of the individual with whom you are working.  A diagnosis of 
cancer and its associated treatment bring with it unique barriers to regular participation in exercise.  
However, these are not the only factors to be considered when prescribing exercise to this 
population.  Overcoming ‘typical’ exercise barriers, such as affordability, time constraints, lack of 
interest/motivation, etc, which may be exacerbated or reduced as a consequence of the cancer 
experience, should also be considered, discussed and resolved. 
 
Need for Caution  
In the past, when dealing with cancer patients, vigorous exercise has been avoided, as have high-
impact types of activity.  Furthermore, cancer survivors with particular side-effects such as 
lymphoedema have until recently been excluded from participating in exercise intervention studies, for 
fear of exacerbating this condition.  As more evidence accumulates, it appears that this rest strategy 
has actually exacerbated problems facing cancer patients.  We must continue to be cautious when 
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prescribing exercise to special populations.  However, at the same time, we must ensure that cancer 
survivors are provided with AEP-prescribed exercise programs with appropriate type, intensity and 
duration, to ensure beneficial outcomes.  For example, it makes sense that patients with bony 
metastasis avoid high-impact activities and/or activities that increase risk of falls.  However, this same 
advice may not be appropriate for a woman who has completed treatment for breast cancer and enjoys 
the social and physical aspect of a game of netball.  We must overcome the perception that cancer 
patients should pursue rest or only ‘gentle exercise’.  Such a strategy is ineffective at stimulating the 
neuromuscular, endocrine, immune and skeletal systems for symptom reduction and health 
enhancement.   
 
Fatigue and lymphoedema merit special attention, as they represent cancer symptoms that have 
previously been treated with rest.  It is now understood that exercise participation during and/or after 
cancer treatment at worst does not exacerbate fatigue[32].  It is also known that failure to participate in 
a progressive exercise program could potentially exacerbate fatigue rather than prevent or minimise 
it[33].  With rest, or when physical activity levels are down-regulated, a detrimental cycle of 
diminished activity which leads to reduced function and subsequent fatigue is initiated.  As for 
lymphoedema, evidence is accumulating to demonstrate that participation in an exercise program does 
not increase lymphoedema risk or exacerbate the condition if already present[34-36].  Restricting the 
involvement in exercise of cancer survivors with fatigue or secondary lymphoedema may limit their 
opportunity to participate in a potential rehabilitative strategy that could lead to significant benefits for 
their physical and psychosocial wellbeing, as well as adversely influence their prognosis (risk of 
recurrence or survival).  Nevertheless, our exercise prescription knowledge for this population remains 
somewhat limited. 
 
While the literature supports the view that exercise should be incorporated during and following 
cancer treatment, this philosophy is not held by all.  Resistance may be encountered from clinicians, 
other allied health professionals, as well as family and friends of cancer patients.  Often the resistance 
is a consequence of lack of understanding with respect to what an individualised exercise program 
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means (e.g. perception that what is moderate intensity for them is the same for everyone) and/or 
concern that exercise may cause harm (e.g., usually due to limited appreciation for the harm caused by 
inactivity).  With time, persistence and a respectful, educated approach this resistance will likely 
become support.  
 
Current status of opportunities for Accredited Exercise Physiologists  
Despite the high prevalence of physical and psychosocial impairment among cancer survivors, as well 
as the recognition that cancer rehabilitation is an essential component of cancer care, exercise 
rehabilitation does not yet form part of standard care.  If patients have the inclination and knowledge, 
they may access resources available within the community to assist in their rehabilitative endeavours.  
These are somewhat limited, with greater options being available for breast cancer survivors.  On a 
national front, the Cancer Councils of Australia provide counselling services, information, support 
services and offer a ‘living with cancer’ education program.   The YWCA’s ‘Encore program’ is also 
available for women with breast cancer and some hospitals may provide their own rehabilitative 
programs.  However, of the programs available in Australia, few address both the psychosocial as well 
as physical concerns of the cancer survivor.  Of those that do encompass some form of exercise, the 
prescriptive characteristics are generally below what current research recommends and focus on 
specific areas only (e.g. shoulder and arm function for breast cancer patients) rather than embracing a 
whole-body approach.  Therefore, there exists a significant role for the AEP in the care of people with 
cancer. 
 
Additionally, the quality of research in the exercise and cancer domain varies.  More rigorous, 
randomised, controlled trials that are well described, involving larger sample sizes and population-
based samples are required to advance our understanding regarding the impact of physical activity on 
cancer-related outcomes, for prevention and treatment.  Furthermore, the potential benefits of exercise 
in relation to cancer is a focus of growing concern, with expanded opportunities for postgraduate 
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education, including training to work with the special population of cancer patients and survivors as 
well as training to conduct research on exercise prescription in relation to cancer prevention. 
 
Conclusions  
Accredited exercise physiologists can influence public health through the prescription of exercise for 
the prevention of cancer, supporting the medical management of cancer, as well as optimising 
recovery following cancer diagnosis.  While the optimal exercise prescription remains unknown, and 
may depend on the type of cancer, the cancer treatment undertaken and the characteristics of the 
patient, it is clear that participation in some activity is better than none, and that more is generally 
better than less, at least up to levels meeting national physical activity guidelines.  There are now well-
defined physical and psychological problems associated with cancer and its treatment that respond 
well to appropriate exercise. Therefore, exercise prescription with this population should be seen as 
vital adjuvant therapy aimed at maintaining or improving structure and function, alleviating 
symptoms, and assisting recovery of survivors or slowing decline of palliative patients. Regardless, the 
overarching goal should be to enhance quality of life, and the social and interpersonal interactions 
derived from exercise are critical components of this process.  
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Table 1: Summary of potential benefits of exercise during and/or following cancer treatmenta  
Preservation or improvements:  Reductions: 
Muscle mass, strength, power 
Cardiorespiratory fitness 
Physical function 
Physical activity levels 
Range of motion 
Immune function 
Chemotherapy completion rates 
Body image, self esteem and mood 
 Number of symptoms and side-effects 
reported, such as nausea, fatigue and pain 
Intensity of symptoms reported 
Duration of hospitalisation 
Psychological and emotional stress 
Depression and anxiety 
 
 a Benefits reported in qualitative, narrative reviews of the literature 
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Table 2: Aerobic-based exercise prescription recommendations during and following cancer treatment 
Parameter Recommendation and Comment 
Type Most exercise involving large muscle groups are appropriate.  Cancer 
survivors do not need to be restricted to walking and stationary cycling.  
Below are examples of when to avoid specific types of activity:  
 Type When to avoid: 
 Swimming During periods of increased risk of infection (e.g., low 
absolute neutrophil counts, when catheters are being used, 
during wound recovery from surgery) 
 High-impact activities or 
contact sports 
Primary or metastatic bone cancer patients, when platelet 
counts are low, presence of bone pain 
 Activities requiring balance 
and coordination (e.g., 
treadmill exercise, cycling) 
Ataxia, dizziness or peripheral sensory neuropathy 
 Use of public facilities (e.g. 
local gymnasium) 
During periods of increased risk of infection 
  
Frequency At least 3-5 times/wk, but daily exercise may be preferable for deconditioned 
patients who do lower intensity and shorter duration exercise sessions 
Intensity Moderate, depending on current fitness level and medical treatments.  
Guidelines recommend 50-75% VO2 max or HRreserve, 60-80% HRmax, or an 
RPE of 11-14 (original Borg scale). HRreserve is the best guideline if HRmax is 
estimated rather than measured.  Examples of when to avoid high intensities 
include low haemoglobin levels, immunosuppressed states or the presence of 
fever.  When nausea, dyspnea, fatigue and/or muscle weakness exist, exercise 
intensity and duration should be prescribed to tolerance.   
Duration At least 20-30 minutes continuous exercise; however, deconditioned patients 
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or those experiencing severe side-effects of treatment may need to combine 
short bouts (e.g., 3-5 minutes) with rest intervals. 
Progression Progression should be slower and more gradual for deconditioned patients or 
those who are experiencing severe side-effects of treatment. Patients should 
meet frequency and duration goals before they increase intensity.  Of note, 
progression for some could actually mean maintenance of weekly activity 
levels or slower declines in total physical activity levels.  That is, declines in 
activity may be inevitable during certain treatment periods, but an exercise 
program can assist in minimising these declines. 
Table has been reproduced and modified, with permission, from Courneya KS, Mackey JR, Jones LW. 
Coping with cancer: Can exercise help? Physician Sportsmed 2000; 28(5):49-73.   
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Table 3:  Resistance-based exercise prescription recommendations during and following cancer 
treatment 
Parameter Recommendation and Comment 
Type • Resistance exercises should be dynamic in nature using both concentric 
(lifting and pushing/pulling phase) and eccentric (controlled 
lowering/returning phase) muscle contractions.  
• Resistance exercises using machine-weights, free weights, body weight 
and/or therabands that involve major functional lower- and upper-body 
muscle groups are appropriate, as are the inclusion of exercises that 
replicate those daily tasks causing problems for patients (e.g. breast cancer 
patients finding hanging clothes on the line troublesome).  
• During periods of increased risk of infection, avoidance of use public 
facilities such as machine-weights in gymnasiums is recommended.   
• Specific resistance exercises such as those using free weights, particularly 
in the absence of a training partner, should be avoided when ataxia, 
dizziness or peripheral sensory neuropathy exists.  
Frequency 1-3 times/week, with rest days between sessions 
Intensity 50-80% 1-repetition maximum or  6-12 repetition maximum 
Duration 6-10 exercises, 1-4 sets per muscle group 
Progression Progression as per described for aerobic exercise. 
Table has been reproduced and modified, with permission, from Galvão DA, Taaffe DR, Spry N, 
Newton RU, Exercise can prevent and even reverse adverse effects of androgen suppression treatment 
in men with prostate cancer. Prostate Cancer and Prostatic Diseases 2007;10(4):340-346.  
 
 
 
 
 
